Literature DB >> 26468492

Preventing Gut Leakiness and Endotoxemia Contributes to the Protective Effect of Zinc on Alcohol-Induced Steatohepatitis in Rats.

Wei Zhong1, Qiong Li1, Qian Sun2, Wenliang Zhang1, Jiayang Zhang3, Xinguo Sun1, Xinmin Yin3, Xiang Zhang3, Zhanxiang Zhou4.   

Abstract

BACKGROUND: Zinc deficiency has been well documented in alcoholic liver disease.
OBJECTIVE: This study was undertaken to determine whether dietary zinc supplementation provides beneficial effects in treating alcohol-induced gut leakiness and endotoxemia.
METHODS: Male Sprague Dawley rats were divided into 3 groups and pair-fed (PF) Lieber-DeCarli liquid diet for 8 wk: 1) control (PF); 2) alcohol-fed (AF; 5.00-5.42% wt:vol ethanol); and 3) AF with zinc supplementation (AF/Zn) at 220 ppm zinc sulfate heptahydrate. The PF and AF/Zn groups were pair-fed with the AF group. Hepatic inflammation and endotoxin signaling were determined by immunofluorescence and quantitative polymerase chain reaction (qPCR). Alterations in intestinal tight junctions and aldehyde dehydrogenases were assessed by qPCR and Western blot analysis.
RESULTS: The AF rats had greater macrophage activation and cytokine production (P < 0.05) in the liver compared with the PF rats, whereas the AF/Zn rats showed no significant differences (P > 0.05). Plasma endotoxin concentrations of the AF rats were 136% greater than those of the PF rats, whereas the AF/Zn rats did not differ from the PF rats. Ileal permeability was 255% greater in the AF rats and 19% greater in the AF/Zn rats than in the PF rats. The AF group had reduced intestinal claudin-1, occludin, and zona occludens-1 (ZO-1) expression, and the AF/Zn group had upregulated claudin-1 and ZO-1 expression (P < 0.05) compared with the PF group. The intestinal epithelial expression and activity of aldehyde dehydrogenases were elevated (P < 0.05) in the AF/Zn rats compared with those of the AF rats. Furthermore, the ileal expression and function of hepatocyte nuclear factor 4α, which was impaired in the AF group, was significantly elevated in the AF/Zn group compared with the PF group.
CONCLUSIONS: The results demonstrate that attenuating hepatic endotoxin signaling by preserving the intestinal barrier contributes to the protective effect of zinc on alcohol-induced steatohepatitis in rats.
© 2015 American Society for Nutrition.

Entities:  

Keywords:  HNF-4α; alcohol; alcoholic liver disease; aldehyde dehydrogenase; endotoxemia; intestinal barrier; zinc

Mesh:

Substances:

Year:  2015        PMID: 26468492      PMCID: PMC4656905          DOI: 10.3945/jn.115.216093

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  42 in total

Review 1.  Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology.

Authors:  N E Krebs; K M Hambidge
Journal:  Biometals       Date:  2001 Sep-Dec       Impact factor: 2.949

2.  Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.

Authors:  M Fujimoto; M Uemura; Y Nakatani; S Tsujita; K Hoppo; T Tamagawa; H Kitano; M Kikukawa; T Ann; Y Ishii; H Kojima; S Sakurai; R Tanaka; T Namisaki; R Noguchi; T Higashino; E Kikuchi; K Nishimura; A Takaya; H Fukui
Journal:  Alcohol Clin Exp Res       Date:  2000-04       Impact factor: 3.455

3.  Effect of zinc supplementation on intestinal permeability in experimental colitis.

Authors:  Giacomo Carlo Sturniolo; Walter Fries; Emanuela Mazzon; Vincenza Di Leo; Michela Barollo; Renata D'inca
Journal:  J Lab Clin Med       Date:  2002-05

Review 4.  Influence of ZIP14 (slc39A14) on intestinal zinc processing and barrier function.

Authors:  Gregory J Guthrie; Tolunay B Aydemir; Catalina Troche; Alyssa B Martin; Shou-Mei Chang; Robert J Cousins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-11-26       Impact factor: 4.052

5.  Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine.

Authors:  Cuong D Tran; Gordon S Howarth; Peter Coyle; Jeffrey C Philcox; Allan M Rofe; Ross N Butler
Journal:  Am J Clin Nutr       Date:  2003-05       Impact factor: 7.045

Review 6.  Zinc and alcoholic liver disease.

Authors:  Zhanxiang Zhou
Journal:  Dig Dis       Date:  2011-04-27       Impact factor: 2.404

Review 7.  Zinc and the modulation of redox homeostasis.

Authors:  Patricia I Oteiza
Journal:  Free Radic Biol Med       Date:  2012-08-25       Impact factor: 7.376

Review 8.  Signalling pathways in alcohol-induced liver inflammation.

Authors:  Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Hepatol       Date:  2009-03-28       Impact factor: 25.083

9.  A molecular mechanism for bacterial susceptibility to zinc.

Authors:  Christopher A McDevitt; Abiodun D Ogunniyi; Eugene Valkov; Michael C Lawrence; Bostjan Kobe; Alastair G McEwan; James C Paton
Journal:  PLoS Pathog       Date:  2011-11-03       Impact factor: 6.823

10.  Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors.

Authors:  Wei Zhong; Yantao Zhao; Xinguo Sun; Zhenyuan Song; Craig J McClain; Zhanxiang Zhou
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

View more
  12 in total

1.  Concurrent gut transcriptome and microbiota profiling following chronic ethanol consumption in nonhuman primates.

Authors:  Tasha Barr; Suhas Sureshchandra; Paul Ruegger; Jingfei Zhang; Wenxiu Ma; James Borneman; Kathleen Grant; Ilhem Messaoudi
Journal:  Gut Microbes       Date:  2018-04-27

Review 2.  Zinc deficiency as a mediator of toxic effects of alcohol abuse.

Authors:  Anatoly V Skalny; Margarita G Skalnaya; Andrei R Grabeklis; Anastasia A Skalnaya; Alexey A Tinkov
Journal:  Eur J Nutr       Date:  2017-11-24       Impact factor: 5.614

3.  Role of zinc insufficiency in fetal alveolar macrophage dysfunction and RSV exacerbation associated with fetal ethanol exposure.

Authors:  Juna Konomi Johnson; Frank L Harris; Xiao-Du Ping; Theresa W Gauthier; Lou Ann S Brown
Journal:  Alcohol       Date:  2018-12-21       Impact factor: 2.405

4.  Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia.

Authors:  Natalia Gnatienko; Matthew S Freiberg; Elena Blokhina; Tatiana Yaroslavtseva; Carly Bridden; Debbie M Cheng; Christine E Chaisson; Dmitry Lioznov; Sally Bendiks; Glory Koerbel; Sharon M Coleman; Evgeny Krupitsky; Jeffrey H Samet
Journal:  HIV Clin Trials       Date:  2018-04-17

5.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

6.  Dietary Fisetin Supplementation Protects Against Alcohol-Induced Liver Injury in Mice.

Authors:  Qian Sun; Wenliang Zhang; Wei Zhong; Xinguo Sun; Zhanxiang Zhou
Journal:  Alcohol Clin Exp Res       Date:  2016-08-30       Impact factor: 3.455

Review 7.  Nutrition and Alcoholic Liver Disease: Effects of Alcoholism on Nutrition, Effects of Nutrition on Alcoholic Liver Disease, and Nutritional Therapies for Alcoholic Liver Disease.

Authors:  Srinivasan Dasarathy
Journal:  Clin Liver Dis       Date:  2016-04-23       Impact factor: 6.126

Review 8.  The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective.

Authors:  Kevin De Muynck; Bart Vanderborght; Hans Van Vlierberghe; Lindsey Devisscher
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

Review 9.  Development, Prevention, and Treatment of Alcohol-Induced Organ Injury: The Role of Nutrition.

Authors:  Shirish Barve; Shao-Yu Chen; Irina Kirpich; Walter H Watson; Craig Mcclain
Journal:  Alcohol Res       Date:  2017

10.  Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity.

Authors:  Yuki Fujimoto; Kosuke Kaji; Norihisa Nishimura; Masahide Enomoto; Koji Murata; Soichi Takeda; Hiroaki Takaya; Hideto Kawaratani; Kei Moriya; Tadashi Namisaki; Takemi Akahane; Hitoshi Yoshiji
Journal:  World J Gastroenterol       Date:  2021-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.